These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15188137

  • 1. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ, Hisaoka M, Shi DR, Zhu XZ, Hashimoto H.
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X, Montgomery E, Sun B.
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [Abstract] [Full Text] [Related]

  • 3. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
    Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM.
    Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
    [Abstract] [Full Text] [Related]

  • 4. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
    Cook JR, Dehner LP, Collins MH, Ma Z, Morris SW, Coffin CM, Hill DA.
    Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
    [Abstract] [Full Text] [Related]

  • 5. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
    Cataldo KA, Jalal SM, Law ME, Ansell SM, Inwards DJ, Fine M, Arber DA, Pulford KA, Strickler JG.
    Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA.
    Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
    Coffin CM, Hornick JL, Fletcher CD.
    Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing.
    Yao Q, Bai Q, Zhang X, Ji G, Chang H, Cai X, Yu L, Wang J, Zhu X, Zhou X.
    Arch Pathol Lab Med; 2022 Oct 01; 146(10):1234-1242. PubMed ID: 35041745
    [Abstract] [Full Text] [Related]

  • 12. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL.
    Am J Surg Pathol; 2011 Jan 01; 35(1):135-44. PubMed ID: 21164297
    [Abstract] [Full Text] [Related]

  • 13. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.
    Alassiri AH, Ali RH, Shen Y, Lum A, Strahlendorf C, Deyell R, Rassekh R, Sorensen PH, Laskin J, Marra M, Yip S, Lee CH, Ng TL.
    Am J Surg Pathol; 2016 Aug 01; 40(8):1051-61. PubMed ID: 27259007
    [Abstract] [Full Text] [Related]

  • 14. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
    Chang JC, Zhang L, Drilon AE, Chi P, Alaggio R, Borsu L, Benayed R, Travis WD, Ladanyi M, Antonescu CR.
    J Thorac Oncol; 2019 May 01; 14(5):825-834. PubMed ID: 30550870
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR, Suurmeijer AJ, Zhang L, Sung YS, Jungbluth AA, Travis WD, Al-Ahmadie H, Fletcher CD, Alaggio R.
    Am J Surg Pathol; 2015 Jul 01; 39(7):957-67. PubMed ID: 25723109
    [Abstract] [Full Text] [Related]

  • 16. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
    Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, Makimoto A, Furuta K, Tsuda H.
    Mod Pathol; 2013 Jun 01; 26(6):772-81. PubMed ID: 23307059
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases.
    Leguellec S, Tournier E, Karanian M, Brousset P, Mazereeuw J, Coindre JM, Lamant L.
    Histopathology; 2016 Jan 01; 68(2):297-302. PubMed ID: 26100036
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M, Shimajiri S, Matsuki Y, Meis-Kindblom JM, Kindblom LG, Li XQ, Wang J, Hashimoto H.
    Pathol Int; 2003 Jun 01; 53(6):376-81. PubMed ID: 12787312
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
    Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM.
    Mod Pathol; 2015 May 01; 28(5):732-9. PubMed ID: 25612511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.